Metabolomics and Metabolic Diseases: Where Do We Stand?
暂无分享,去创建一个
[1] R. Kreisberg,et al. Insulin secretion in obesity. , 1967, The New England journal of medicine.
[2] P. Clifton. Diabetes: Treatment of type 2 diabetes mellitus with bariatric surgery , 2010, Nature Reviews Endocrinology.
[3] Nicholette D. Palmer,et al. Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. , 2015, The Journal of clinical endocrinology and metabolism.
[4] Thomas J. Wang,et al. A diabetes-predictive amino acid score and future cardiovascular disease. , 2013, European heart journal.
[5] J. Clemente,et al. Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice , 2013, Science.
[6] M. Jensen,et al. Metabolic cycling in control of glucose-stimulated insulin secretion. , 2008, American journal of physiology. Endocrinology and metabolism.
[7] Svati H Shah,et al. Differential Metabolic Impact of Gastric Bypass Surgery Versus Dietary Intervention in Obese Diabetic Subjects Despite Identical Weight Loss , 2011, Science Translational Medicine.
[8] William L. Lowe,et al. Metabolic Networks and Metabolites Underlie Associations Between Maternal Glucose During Pregnancy and Newborn Size at Birth , 2016, Diabetes.
[9] S. Klein,et al. Effect of Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Gastric Banding on Branched-Chain Amino Acid Metabolism , 2013, Diabetes.
[10] A. Dyer,et al. Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy , 2013, Diabetes Care.
[11] P. Bork,et al. Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.
[12] R. Gerszten,et al. Metabolomic profiling in the prediction of gestational diabetes mellitus , 2015, Diabetologia.
[13] M. Blüher,et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism , 2012, Nature.
[14] S. Hazen,et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis , 2015, Cell.
[15] John P. Overington,et al. An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.
[16] S. O’Rahilly,et al. Human genetics illuminates the paths to metabolic disease , 2009, Nature.
[17] R. Vasan,et al. 2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.
[18] M. Orešič,et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. , 2016, Journal of hepatology.
[19] H. Yki-Järvinen,et al. Non-alcoholic fatty liver disease and risk of type 2 diabetes. , 2016, Best practice & research. Clinical endocrinology & metabolism.
[20] Shuzhao Li,et al. Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study. , 2016, The Journal of pediatrics.
[21] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[22] Chad A. Cowan,et al. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. , 2014, Cell metabolism.
[23] Y. Bao,et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations , 2016, Scientific Reports.
[24] W. Kraus,et al. Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. , 2014, Atherosclerosis.
[25] Svati H Shah,et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.
[26] S. Watkins,et al. GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.
[27] S. Hazen,et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.
[28] Andrea Natali,et al. α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.
[29] Bryan C. Batch,et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss , 2012, Diabetologia.
[30] Jonathan C. Cohen,et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis , 2014, Hepatology.
[31] Olga Ilkayeva,et al. BMI, RQ, Diabetes, and Sex Affect the Relationships Between Amino Acids and Clamp Measures of Insulin Action in Humans , 2014, Diabetes.
[32] M. Patti,et al. Metabolomic profiles and childhood obesity , 2014, Obesity.
[33] D. Altshuler,et al. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. , 2013, Metabolism: clinical and experimental.
[34] Elias Chaibub Neto,et al. Genetic Networks of Liver Metabolism Revealed by Integration of Metabolic and Transcriptional Profiling , 2008, PLoS genetics.
[35] L. Willmitzer,et al. Identification of an intracellular metabolic signature impairing beta cell function in the rat beta cell line INS-1E and human islets , 2011, Diabetologia.
[36] Dorothy D. Sears,et al. Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats. , 2011, American journal of physiology. Endocrinology and metabolism.
[37] C. Newgard. Interplay between lipids and branched-chain amino acids in development of insulin resistance. , 2012, Cell metabolism.
[38] W. Kraus,et al. Metabolic profiles predict adverse events after coronary artery bypass grafting. , 2012, The Journal of thoracic and cardiovascular surgery.
[39] E. Ravussin,et al. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. , 2012, Cell metabolism.
[40] P. Felig,et al. Plasma amino acid levels and insulin secretion in obesity. , 1970, The New England journal of medicine.
[41] Christian Gieger,et al. A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.
[42] G. Bray,et al. FGF21 is an endocrine signal of protein restriction. , 2014, The Journal of clinical investigation.
[43] Ping Li,et al. Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency* , 2005, Journal of Biological Chemistry.
[44] A. Attie,et al. Getting biological about the genetics of diabetes , 2010, Nature Medicine.
[45] Olga Ilkayeva,et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.
[46] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[47] Terho Lehtimäki,et al. Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults , 2013, Diabetes Care.
[48] P. Spégel,et al. Time-resolved metabolomics analysis of β-cells implicates the pentose phosphate pathway in the control of insulin release. , 2013, The Biochemical journal.
[49] B. Zinman,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.
[50] Alan Saghatelian,et al. Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects , 2014, Cell.
[51] C. Gieger,et al. Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.
[52] Charles R. Evans,et al. Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Receptor Signaling Underlies the Fatty Acid Potentiation of Insulin Secretion* , 2014, The Journal of Biological Chemistry.
[53] G. Cline,et al. Integrated, Step-Wise, Mass-Isotopomeric Flux Analysis of the TCA Cycle. , 2015, Cell metabolism.
[54] P. MacDonald,et al. Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. , 2015, Cell reports.
[55] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[56] O. Ilkayeva,et al. Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export , 2016, Molecular metabolism.
[57] Ming-Huei Chen,et al. A genome-wide association study of the human metabolome in a community-based cohort. , 2013, Cell metabolism.
[58] M. Jensen,et al. A Pyruvate Cycling Pathway Involving Cytosolic NADP-dependent Isocitrate Dehydrogenase Regulates Glucose-stimulated Insulin Secretion* , 2006, Journal of Biological Chemistry.
[59] Mei Huang,et al. Assessment of the metabolic pathways associated with glucose-stimulated biphasic insulin secretion. , 2014, Endocrinology.
[60] Tuija Tammelin,et al. Metabolic Signatures of Insulin Resistance in 7,098 Young Adults , 2012, Diabetes.
[61] W. Kraus,et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. , 2012, American heart journal.
[62] Jonathan C. Cohen,et al. Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease* , 2011, The Journal of Biological Chemistry.
[63] L. Groop,et al. α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance , 2016, Diabetes Care.
[64] Geoffrey S Ginsburg,et al. Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.
[65] W. Kraus,et al. Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans , 2015, Diabetologia.
[66] B. Zinman,et al. Evaluation of Circulating Determinants of Beta-Cell Function in Women With and Without Gestational Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.
[67] B. Kahn,et al. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. , 1993, The Journal of biological chemistry.
[68] M. Ravier,et al. Hierarchy of the β‐cell signals controlling insulin secretion , 2003, European journal of clinical investigation.
[69] B. Kahn,et al. Adipose Tissue Branched Chain Amino Acid (BCAA) Metabolism Modulates Circulating BCAA Levels* , 2010, The Journal of Biological Chemistry.
[70] H. Ashktorab,et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations , 2016, Digestive Diseases and Sciences.
[71] Y. Liu,et al. Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development. , 2016, Cell reports.
[72] O. Ilkayeva,et al. Sex differences in biomarkers associated with insulin resistance in obese adolescents: metabolomic profiling and principal components analysis. , 2014, The Journal of clinical endocrinology and metabolism.
[73] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Network Boston.
[74] G. Siuzdak,et al. Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.
[75] Qiong Yang,et al. An exome array study of the plasma metabolome , 2016, Nature Communications.
[76] P. Toth. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans , 2011 .
[77] P. Saha,et al. Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease , 2008, Science.
[78] E. Tai,et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men , 2010, Diabetologia.
[79] Nicola Zamboni,et al. Defining the metabolome: size, flux, and regulation. , 2015, Molecular cell.
[80] R. Quintens,et al. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. , 2005, Diabetes.
[81] M. Prentki,et al. Metabolic Fate of Glucose in Purified Islet Cells , 1997, The Journal of Biological Chemistry.
[82] Christian Gieger,et al. Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.
[83] J. Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.
[84] V. Mootha,et al. Circulating branched‐chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents , 2013, Pediatric obesity.
[85] B. Cox,et al. A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes , 2016, Diabetes.
[86] M. Kleber,et al. Childhood Obesity Is Associated with Changes in the Serum Metabolite Profile , 2012, Obesity Facts.
[87] John B Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.
[88] W. Kraus,et al. Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis , 2015, PLoS genetics.
[89] S. A. Arriola Apelo,et al. Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health. , 2016, Cell reports.
[90] Pengxiang She,et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.
[91] Brett R. Wenner,et al. Metabolomics Applied to Diabetes Research , 2009, Diabetes.
[92] P. Neufer,et al. Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. , 2015, The Journal of clinical investigation.
[93] Jiandie D. Lin,et al. Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism , 2008, Proceedings of the National Academy of Sciences.
[94] Joerg M. Buescher,et al. A roadmap for interpreting (13)C metabolite labeling patterns from cells. , 2015, Current opinion in biotechnology.
[95] S. Watkins,et al. Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.
[96] M. Rewers,et al. Metabolomics in childhood diabetes , 2016, Pediatric diabetes.
[97] P. Saha,et al. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. , 2010, Cell metabolism.
[98] T. Shlomi,et al. Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.
[99] William E. Kraus,et al. Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women , 2009, Diabetes Care.
[100] O. Ilkayeva,et al. Muscle-Specific Overexpression of PGC-1α Does Not Augment Metabolic Improvements in Response to Exercise and Caloric Restriction , 2014, Diabetes.
[101] C. Burant,et al. Metabolome Response to Glucose in the β-Cell Line INS-1 832/13* , 2013, The Journal of Biological Chemistry.
[102] David Millington,et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.
[103] M. Jensen,et al. The Mitochondrial Citrate/Isocitrate Carrier Plays a Regulatory Role in Glucose-stimulated Insulin Secretion* , 2006, Journal of Biological Chemistry.
[104] Xian Chen,et al. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. , 2012, Cell metabolism.
[105] William E. Kraus,et al. Basic Science for Clinicians Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases Form and Function , 2012 .
[106] G. Shulman,et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver , 2001, Nature.
[107] Geoffrey S Ginsburg,et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease , 2009, Molecular systems biology.
[108] SoJung Lee,et al. Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. , 2012, The Journal of clinical endocrinology and metabolism.
[109] I. G. Fantus,et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. , 2014, Cell metabolism.
[110] H. Mulder,et al. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.